BioNTech

Ljubljana – The National Institute of Public Health (NIJZ) expects new batches of Covid-19 vaccines this week, consisting of 21,060 doses of Pfizer/BioNTech vaccine, and 16,800 of the AstraZeneca vaccine. The national vaccination strategy has been updated in the part setting the priority groups, the NIJZ told the STA.

The National COVID Vaccination Coordination Committee (CNCAV) informs that according to data provided by the National Public Health Institute through the National Electronic Vaccinations Registry app, 37,137 people have received the coronavirus jab in the past 24 hours, with 27,290 injected with the Pfizer vaccine, 3,035 with the Moderna, and 6,812 with the AstraZeneca serum.

Europe's medicines regulator is planning to speed up assessments of any Covid-19 vaccines that are modified to protect against variants of the virus, the head of the agency's Covid-19 task-force told Reuters on Friday.

The National Committee for Vaccination against COVID (CNCAV) informs that, in the past 24 hours, 39,376 doses of vaccine were administered, of which 35,756 doses of Pfizer and 3,620 doses of Moderna, according to data made available by INSP (Public Health Inspectorate) through the National Electronic Vaccination Registry application.

Today, 31,200 doses of AstraZeneca Covid-19 vaccine arrived at the BulBio warehouse in Sofia, the health ministry reported.

They will be distributed among the regional health inspectorates in the country. This is a second shipment of the vaccine. The first shipment of 28,800 doses arrived on February 6.

The European Commission has so far approved all requests for the export of Covid-19 vaccines, including to Britain, the United States and Japan, since it set up on January 30 a mechanism to monitor vaccine trade, a spokeswoman said on Thursday.

Greek Police is investing the mysterious loss of a Pfizer vaccine vial from a vaccination center in the district of Peristeri, northwestern Attica, on Wednesday afternoon.

Ljubljana – Slovenia currently has 2% of its population vaccinated against coronavirus and if the supply of vaccines continues at current pace, 5% of the population could be vaccinated by the end of the month, said Marta Grgič Vitek, the coordinator of the vaccination programme at the National Institute of Public Health (NIJZ).

Turkey targets to vaccine 60% of its population, with the second doses of vaccines for people who got the first jab starting on Feb. 11, the country's health minister said on Feb. 10.

Turkish-German scientist Uğur Şahin, who developed the Pfizer-BioNtech coronavirus vaccine together with his wife Dr. Özlem Türeci, will likely invest in Turkey to establish a medical research center, according to Mustafa Varank, Turkey's industry and technology minister.